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Abstract
Epidemiological studies have shown that cigarette smoking is a major risk factor for tubal ectopic pregnancy but the reason
for this remains unclear. Here, we set out to determine the effect of smoking on Fallopian tube gene expression. An
oviductal epithelial cell line (OE-E6/E7) and explants of human Fallopian tubes from non-pregnant women (n = 6) were
exposed to physiologically relevant concentrations of cotinine, the principle metabolite of nicotine, and changes in gene
expression analyzed using the Illumina Human HT-12 array. Cotinine sensitive genes identified through this process were
then localized and quantified in Fallopian tube biopsies from non-pregnant smokers (n = 10) and non-smokers (n = 11) using
immunohistochemistry and TaqMan RT-PCR. The principle cotinine induced change in gene expression detected by the
array analysis in both explants and the cell line was significant down regulation (P,0.05) of the pro-apoptotic gene BAD. We
therefore assessed the effect of smoking on cell turnover in retrospectively collected human samples. Consistent with the
array data, smoking was associated with decreased levels of BAD transcript (P,0.01) and increased levels of BCL2 transcript
(P,0.05) in Fallopian tube biopsies. BAD and BCL2 specific immunolabelling was localized to Fallopian tube epithelium.
Although no other significant differences in levels of apoptosis or cell cycle associated proteins were observed, smoking was
associated with significant changes in the morphology of the Fallopian tube epithelium (P,0.05). These results suggest that
smoking may alter tubal epithelial cell turnover and is associated with structural, as well as functional, changes that may
contribute to the development of ectopic pregnancy.
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Introduction
Ectopic pregnancy occurs in 1–2% of all pregnancies in Europe
and the United States [1]. In the Western world, it remains the
most common life-threatening early pregnancy complication [1,2].
Over 98% of ectopic pregnancies implant in the Fallopian tube
but the aetiology of tubal implantation is largely unknown [3].
Nevertheless, descriptive observations support the hypothesis that
tubal implantation is likely caused by embryo retention within the
Fallopian tube due to impaired tubal transport and alterations in
the tubal microenvironment allowing early implantation to occur.
Transport of the embryo through the Fallopian tube is controlled
by a combination of smooth muscle contractility and ciliary
beating [4,5]. The factors that regulate and maintain the normal
tubal microenvironment are largely unknown.
Epidemiological studies have shown that cigarette smoking is a
major risk factor for tubal ectopic pregnancy (adjusted OR 1.7–
3.9) [6]. Animal and human studies have demonstrated effects on
oviductal/Fallopian tube function resulting from smoke exposure
[7,8]. Despite these findings, the exact mechanism by which
cigarette smoking leads to ectopic pregnancy remains uncertain.
We recently reported that cotinine (an active metabolite of
nicotine) increases the expression of prokineticin PROKR1 in the
Fallopian tube, a regulator of smooth muscle contractility and a
gene thought to be important for intrauterine implantation [9].
We proposed that cigarette smoking attenuates tubal PROKR1
expression resulting in changes in Fallopian tube function,
providing a possible explanation for the link between smoking
and tubal ectopic pregnancy. In this study, we take this finding
forward by investigating how smoking alters global gene expres-
sion and function of tubal epithelial cells.
Materials and Methods
Human Fallopian Tube and Serum Collection
Ethical approval for this study was obtained from the Lothian
Research Ethics Committee (04/S1103/20), and informed written
consent was obtained from all of the women participating in the
study. Serum samples (10 ml) and Fallopian tube biopsies (2–3 cm)
from the ampullary region of the Fallopian tube were collected
from participants at the time of hysterectomy for benign
gynaecological conditions. Women were between 18 and 45 years
of age. All biopsies were collected in the mid-luteal phase of the
menstrual cycle, and cycle phase was later confirmed by estradiol
and progesterone levels measured in the serum samples as
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described previously [10]. A smoking history was obtained from all
patients. In the first part of the study biopsies from non-smokers
(n = 3) were transferred to the laboratory in phosphate-buffered
saline (PBS) for explant culture [9]. In the second part of the study
biopsies (n = 21) were divided into equivalent portions and i)
immersed in RNAlater (Ambion, Texas, USA) at 4uC overnight
and then flash frozen at 280uC for RNA extraction, or ii) fixed in
4% neutral-buffered formalin overnight at 4uC followed by storage
in 70% ethanol, and subsequent embedding in paraffin wax for
immunohistochemical staining. Serum samples were stored at 2
20uC until analysis. Altman’s nomogram indicates that a sample
size of 8 in each group will have 80% power at the 5% significance
level to show a difference of $1.4 standard deviations between the
two groups, if one truly exists.
Measurement of Serum Cotinine Concentrations
Serum cotinine concentrations were measured using the direct
cotinine ELISA kit (Immunalysis, Pomona, CA), according to the
manufacturer’s instructions. ELISA data were analyzed in
conjunction with the smoking history provided by the participants.
A very strong relationship was observed between serum cotinine
concentrations and the self-reported smoking status of the patients
[9]. All smokers had serum cotinine concentrations in excess of
160 ng/ml while the concentration in the serum of non-smokers
did not exceed 12 ng/ml, confirming that cotinine is a good
biomarker for smoking. As non-smokers have serum cotinine levels
less than 40 ng/ml [9] we used this cut off to divide the samples
into two groups: a) non-smokers (cotinine,40 ng/ml) (n = 11) and
b) smokers (cotinine .40 ng/ml) (n = 10).
Exposure of the Immortalised Oviductal Epithelial Cell
Line (OE-E6/E7) to Cotinine
OE-E6/E7 cells [11] were maintained in DMEM/F12 medium
supplemented with 10% fetal bovine serum (growth medium) in
5% CO2 at 37uC. Cells were seeded at 500,000 cells per well in
12-well dishes and incubated for 24 hours. The growth medium
was then removed and cells washed once with PBS, after which
serum-free DMEM/F12 (maintenance medium) was added and
the cells maintained overnight. The cells were then exposed to
40 ng/ml cotinine (n = 3) (Sigma-Aldrich, Dorset, UK), which
represents cotinine concentrations found in the serum of passive
smokers, and 400 ng/ml (n = 3), the average concentration found
Figure 1. Diagram comparing array data in each of the four
analytical groups. In the OE-E6/7 cell line the addition of 40 ng/ml
cotinine (‘Low Cell’) altered the expression of 946 genes (increasing 585
genes and reducing the expression of 361 genes). Of the 676 genes
(361 increased and 315 reduced) altered by the addition of 400 ng/ml
cotinine (‘High Cell’), 135 were shared with the ‘Low Cell’ treatment. In
FT explants the addition of 40 ng/ml cotinine (‘Low Tissue’) altered the
expression of 596 genes (137 increased and 459 reduced). Explant
treatment with 400 ng/ml cotinine (‘High Tissue’) changed 2419 genes
(increasing 313 and reducing 2106), 265 of which were shared with the
‘Low Tissue’ treatment. The effect of cotinine in Fallopian tube therefore
is mainly to inhibit gene expression. When comparing the effect of
cotinine in the OE-E6/7 cells when compared to FT explants common
were genes identified. There were 16 altered genes the ‘Low Tissue’
group shared with the ‘Low Cell’ group and 27 genes shared with the
‘High Cell’ group. There were 111 genes that changed expression in
common between the ‘High Tissue’ and ‘Low Cell’ group and 54 with
the ‘High Cell’ group. There was only one up-regulated gene and one
down regulated gene in common to all groups.
doi:10.1371/journal.pone.0089400.g001
Figure 2. TaqMan RT-PCR analysis of BAD and BCL2 transcript
abundance in FT from smokers and non-smokers. Relative
expression of BAD (A) and BCL2 (B) in the FT of non-smokers (clear bars:
n = 11) and smokers (filled bars: n = 10). Observed differences are
significant at * P,0.05, **P,0.01. Gene expression was related to a
G6PDH internal control.
doi:10.1371/journal.pone.0089400.g002
Why Smoking Is BAD for Your Fallopian Tube
PLOS ONE | www.plosone.org 2 February 2014 | Volume 9 | Issue 2 | e89400
in the serum of active smokers [12]. All cells, including controls,
(n = 3) were treated with an equivalent amount of ethanol (0.16%
v/v) to control for the cotinine diluent. Cells were treated for 8
hours (the time taken for changes in gene expression to be
observed in our previous study) [9] and medium was then removed
and cells harvested into 300 ml of RLT buffer (Qiagen, West
Sussex, UK) containing 10 ml/ml b-mercaptoethanol and stored
at 280uC until RNA extraction. All experiments were performed
in triplicate (and replicates pooled). RNA was extracted using the
RNA easy kit (Qiagen, West Sussex, UK), according to the
manufacturer’s instructions which included a DNase treatment
step. RNA concentrations were then quality tested and quantified
using a Nanodrop Spectrophotometer (Thermo Scientific, Wil-
mington, DE).
Exposure of Human Fallopian Tube Explants to Cotinine
Fallopian tube explant culture was performed as previously
described [9]. Explants were exposed to 0 ng/ml (n = 3), 40 ng/ml
(n = 3) or 400 ng/ml cotinine (n = 3) and again treated with
equivalent amounts of ethanol to control for the cotinine diluent.
Treatments were performed on duplicate explants (which were
later pooled) for 8 hours, at which time the culture medium was
removed and tissues placed in 300 ml of Trizol reagent (Invitrogen,
Paisley, UK) and frozen at 280uC until RNA extraction. RNA
was extracted using Trizol (Invitrogen) according to the manu-
facturer’s instructions. After RNA extraction, DNAase treatment
was performed followed by sample clean-up using the RNAeasy kit
(Qiagen, West Sussex, UK). After extraction, RNA concentrations
were quantified as described above.
Microarray Analysis of OE-E6/7 Cells and Fallopian Tube
Explants Exposed to Cotinine
The effect of cotinine on cell and tubal gene expression was
examined using Illumina Human HT-12 microarrays. Array
analysis was performed in GeneSpring GX 12.0 (Agilent
Technologies). Raw data were pre-processed to remove variability
across and within array samples. To minimize non-biological
variability across arrays raw data was log2 transformed and then
quantile normalised. Further downstream filtering of the normal-
ised array data was performed to remove invariant transcripts
based on quality flags and normalised expression values. Heat
maps based on average fold-changes (FC) for each gene in the
array were generated to visualize the level of correlation between
the individual samples and treatment groups and showed that the
arrays demonstrated a high degree of correlation between samples.
Protocols of the experimental procedures, methods of analysis and
microarray data are available as supplementary information in the
European Bioinformatics Institute’s MIAME compliant ArrayEx-
press database (http://www.ebi.ac.uk/arrayexpress website).
Analysis of differential gene expression was performed as
previously described [13]. Briefly, after explorative assessment, a
rigorous statistical analysis was exploited to identify differentially
expressed genes. The four treatment groups [Low Cell (40 ng/ml
OE-E6/7: n= 3), High Cell (400 ng/ml OE-E6/7: n= 3), Low
Figure 3. Immunohistochemistry. A) BAD (brown) is expressed in the epithelium (E), most prominently towards the lumen (L), of the FT and not
in the stroma (S). B) BCL2 (brown) immunolabelling showing predominant epithelial staining with occasional cell staining in the stroma. C) Higher
power BCL2 immunolabelling showing no staining in the ciliated epithelial cells (black arrow) with staining in interspaced cells with no obvious cilia
(red arrow). D) Scanning EM highlighting the two populations of epithelial cells with and without cilia. E) Apoptotic cells (brown) identified by
immunolabelling for cleaved caspase 3. The arrow shows an apoptotic cell in the tubal epithelium. F) Higher power view showing a cell stained for
cleaved caspase 3 (arrow) at the epithelial and stromal junction. G) Cells stained by the proliferation marker Ki-67 (brown). H) Higher power view
showing a cell stained for Ki-67 (arrow) in the tubal epithelium. I) Representative image of a section of FT from a smoker immunostained for BAD
showing the apical smooth protuberances or ‘epithelial bledding’ (arrow). J) Section of FT immunostained for BAD with the ciliated epithelial cells
with no surface ‘epithelial blebbing’.
doi:10.1371/journal.pone.0089400.g003
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Tissue (40 ng/ml explant: n = 3), High Tissue (400 ng/ml explant:
n = 3)] were compared to the respective diluent (ethanol) only
control samples (n = 3 per group) using pairwise T-test compar-
isons with a P-value cut-off of ,0.05 and a fold change cut-off of
.1.1. The lists of genes identified by this method were compared
between each of the four analytical groups and any gene matches
recorded.
Quantitative RT-PCR for Fallopian Tube Gene Expression
Messenger RNA was extracted from the FT samples as
described previously [10] and reverse transcribed into cDNA
using random hexamers (Applied Biosystems, Foster City, CA,
USA). Quantitative real-time PCR (QRT-PCR) was carried out
on the ABI PRISM 7900 heat-cycler sequence detection system
(Applied Biosystems) using specific previously-validated primers
(Table S1 in File S1) (Eurogentec Ltd., Southampton, UK). Gene
expression was related to a G6PDH internal control (Applied
Biosystems). Negative controls included Taq polymerase omission,
RT negative (containing template hRNA but no RT enzyme) and
RT water (containing RT but no template RNA). All samples were
analyzed in duplicate and a relative comparison was made to
human corpus luteum cDNA [14]. All statistical analyses were
performed using Prism (GraphPad Software, La Jolla, USA). A
two-tailed t-test was used if the data were normally distributed
Figure 4. Assessment of cell death in the FT. A) Frequency of immunopositive cells in the FT of non-smokers (clear bars: n = 11) and smokers
(filled bars: n = 10). Relative expression of of CASP3 (B) and CASP9 (C) transcripts within the FT of smokers and non smokers and (D) their correlation to
each other in a single FT sample. Observed differences are significant at * P,0.05. Gene expression was related to a G6PDH internal control.
doi:10.1371/journal.pone.0089400.g004
Figure 5. Assessment of changes in cell proliferation and morphology in the FT of smokers. A) Frequency of Ki67 positive cells in the FT
of non-smokers (clear bars: n = 11) and smokers (filled bars: n = 10). B) Relative expression of Cyclin D1 transcripts within the FT of smokers and non
smokers Expression of CCND1 in the FT of smokers and non smokers. C) Histoscore analysis of the degree of ‘epithelial blebbing’ in non-smokers
compared to smokers. Observed differences are significant at * P,0.05. Gene expression was related to a G6PDH internal control.
doi:10.1371/journal.pone.0089400.g005
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with similar standard deviations otherwise a non-parametric
Mann–Whitney test was used. Differences were considered
significant when P,0.05.
Immunohistochemistry of the Fallopian Tube
Formal-saline fixed paraffin wax embedded (FFPE) sections
were mounted on Snow Coat X-tra charged slides (Surgipath
Europe, Peterborough, UK), dewaxed in xylene, rehydrated and
subjected to antigen retrieval by pressure cooking for 20 minutes in
10 mM sodium citrate (pH 6.0), before blocking endogenous
peroxidase with 3% hydrogen peroxidase (Sigma, Dorset, UK). An
avidin–biotin block (Vector Laboratories, Peterborough, UK) and
protein block (Dako, Ely, UK) were performed prior to overnight
incubation with primary antibodies (Table S2 in File S1). Negative
controls included incubation with equivalent concentrations of
non-specific immunoglobulins and omission of the primary
antibody. Sections were then incubated with biotinylated second-
ary antibody and ABC-Elite (Vector Laboratories). Positive
immunolabelling was visualized using 3,3-diaminobenzidine (Im-
mPACT DAB: Vector Laboratories). Sections were then counter-
stained counterstained in Mayer’s Haematoxylin and mounted
with No. 1.5 glass coverslips using Pertex (Cellpath PLC, Hemel
Hempstead, UK).
Analysis of Immunostaining
Histological images were captured using an Olympus Provis
BX2 microscope (Olympus America Inc. Center Valley, PA, USA)
equipped with a Canon E0S 30D Microcam camera (Canon Inc
Headquarters, Tokyo, Japan). B cell leukemia/lymphoma 2
(BCL2) and BCL2-associated agonist of cell death (BAD) epithelial
immunolabelling intensity, and the degree of surface blebbing in
the sections stained for BAD, were graded on a four-point scale by
two observers blinded to tissue identity, with excellent correlation,
and averaged. Statistical analysis was conducted using a Mann–
Whitney test. For assessment of number of cleaved caspase 3 and
Ki-67 positive cells five fields were identified and captured using a
stratified random sampling technique. Using Image J (http://
rsbweb.nih.gov/ij/) software with thresholding both the number of
nuclei and the number of immunostained cells were counted.
Statistical analysis was conducted using a Mann Whitney test.
Scanning Electron Microscopy
Representative portions of the Fallopian tube biopsies fixed in
neutral buffered formalin were dehydrated through a series of
aqueous solutions of ethanol (50 to 100% v/v). Scanning electron
microscopy was performed as previously described [15]. Briefly,
the specimens were critical point dried from liquid CO2 and
mounted on carbon-coated aluminum stubs, and coated with
evaporated carbon using an Edwards 306 vacuum coating unit.
The samples were subsequently examined using a Cambridge
Stereoscan S360 electron microscope (KE Developments, UK).
The accelerating voltage was 15 kV.
Results
Microarray Analysis of Cotinine Treatment on Cells and
Explants
Microarray data are available as supplementary information in
the European Bioinformatics Institute’s MIAME compliant
ArrayExpress database http://www.ebi.ac.uk/arrayexpress web-
site: accession number E-MTAB-12390. After explorative analysis
of the microarray data, a rigorous statistical analysis was exploited
to identify differentially expressed genes. We then conducted
pairwise comparisons between Fallopian tube explant and
oviductal epithelial cell lines exposed to each concentration of
cotinine and control samples with a p-value cut-off of ,0.05 and a
fold change cut-off of .1.1, i.e. a 10% difference in expression of
up- or down-regulated genes. The lists of genes identified by this
method were compared between each of the four analytical groups
and any gene matches recorded (summarized in Figure 1).
However there was only one up-regulated gene and one down
regulated gene in common to all groups. The down-regulated gene
highlighted was the pro-apoptotic gene BAD and the up-regulated
gene was the cell cycle associated gene NCL. It therefore seems that
both the cell and tissue effects of cotinine in vitro relate to
regulation of cell turnover. We therefore used this finding as a
starting point to assess the effect of smoking on cell turnover in
retrospectively collected human Fallopian tube biopsies from
smokers and non-smokers, focusing on the BAD/BCL2 pathway.
BAD Expression is Significantly Reduced in Fallopian
Tube of Smokers and BCL2 Expression is Increased When
Compared to Non-smokers
NCL expression was not altered in the FT of smokers when
compared to non-smokers (data not shown). However, the
expression of BAD mRNA was significantly lower (approximately
1.5 fold; P,0.01) and expression of BCL2 was found to be
significantly higher (approximately 1.5 fold; P,0.05) in Fallopian
tube from smokers compared to Fallopian tube from nonsmokers
(Figure 2). These data suggest an association between FT BAD and
BCL2 expression, serum cotinine, and cigarette smoking.
BAD and BCL2 are Localized to Fallopian Tube Epithelium
The epithelium of the ampullary region of the human Fallopian
tube was found to express both BAD and the pro-survival gene
BCL2 by immunohistochemistry (Figure 3A–C). Although BAD
appears to be constitutively expressed in the cytoplasm of all of the
epithelial cells, BCL2 is expressed in some epithelial cells and not
others. High power analysis shows that it appears to be absent in
the ciliated cells (Figure 3B) and expressed in the non-ciliated cells
whose surface has a more bleb-like appearance (Figure 3C). These
different cell types in the FT epithelium can clearly be seen using
scanning EM (Figure 3D).
Caspases and Cell Death in Fallopian Tube of Smokers
Compared to Non-smokers
In order to investigate the effect of altered BAD and BCL2
expression in the FT we immunolocalized cleaved caspase 3 to
identify apoptotic cells in tissue sections (Figure 3E and F). Cells
expressing cleaved caspase 3 could be identified in both smokers
and non-smokers, and although the numbers were less in smokers
this did not reach statistical significance (Figure 4A). Likewise the
trend to reduced CASP3 and CASP9 expression (Figure 4B and C)
did not reach significance although their expression was correlated
(r = 0.5, P,0.05; Figure 4D). Overall this suggests that there may
be a non-significant trend to reduced cell death in the tubal
epithelium of smokers.
Epithelial Cell Proliferation in the Fallopian Tube of
Smokers Compared to Non-smokers
We assessed cell proliferation using immunolocalization of Ki-
67 (Figure 3G and H). There were dividing cells in the tubal
epithelium from smokers and non-smokers. Although there were
more proliferating cells in the FT of smokers this did not reach
statistical significance (Figure 5A). In addition the increase in
CCND1 (Figure 5B) did not reach significance. Overall however
this suggests that there may be a trend to increased cell
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proliferation in the tubal epithelium of smokers. Taken together
with the data on cell death there is a strong suggestion that
smoking might affect cell FT epithelial cell turnover. We therefore
assessed if this was associated with structural changes of the
Fallopian tube.
Evidence of Cell-surface Irregularity in the Tubal
Epithelium of Smokers
The immunolabelling of FT sections with BAD highlighted
epithelial features less visible in the negative control sections. Some
epithelial cells, and areas of epithelium, had more obvious apical
BAD staining in some sections than in others (Figure 3I and J). We
termed these epithelial cellular protrusions as ‘epithelial blebbing’
and blind scoring for degree of ‘epithelial blebbing’ on a four point
scale indicated that they were significantly higher in Fallopian tube
from smokers compared to Fallopian tube from nonsmokers
(Figure 5C). This suggests that possible alterations in cell turnover
associated with smoking may alter tubal structure and subse-
quently its function.
Discussion
Our in vitro array studies indicate that cotinine exposure appears
to affect expression of genes involved in epithelial cell turnover.
We subsequently demonstrate that Fallopian tube biopsies from
smokers exhibit evidence of an anti-apoptotic profile (reduced
BAD, increased BCL2), a trend towards increased cellular
proliferation and decreased cell death, and structural changes in
epithelial cell surface structure. These results suggest that smoking
may alter epithelial cell turnover in the Fallopian tube, and the
resulting structural alteration may help explain the link between
smoking and tubal ectopic pregnancy. Cigarette smoking is also
associated with other adverse effects on human reproduction, in
addition to tubal ectopic pregnancy, such as infertility and
spontaneous abortion, making this is an important finding in the
broader context of reproductive health [16].
These results are biologically plausible. Outside the reproduc-
tive tract, nicotine in cigarette smoke is well known to pro-survival,
inhibiting apoptosis and activating survival pathways in the
context of other pathologies, such as lung cancer [17]. In the rat
tongue mucosa, BAD expression did not change following
exposure to cigarette smoke whereas BCL2 was overexpressed
[18]. In addition BCL2 over-expression in response to cigarette
smoke has also been reported in an earlier study in the context of
head and neck cancer [19]. The similar findings in oral and
respiratory cells and the FT suggest the involvement of a
circulating product of smoking rather than a purely topical effect.
As this product may be cotinine it would be interesting to study
whether nicotine replacement therapy is associated with tubal
ectopic pregnancy.
In contrast to our observations in the FT, Hu et al [20] reported
that cigarette smoke extract has the opposite effect in human
airway smooth muscle cells – increasing expression of BAD and
decreasing expression of BCL2. One potential explanation is a
topical effect of other constituents of smoke or associated changes
in the function of the p53 gene [21] that transcriptionally up-
regulates BAD expression by binding to its p53-responsive element
[22]. In addition the apoptotic activity and pro-survival activity of
BAD and BCL2 are respectively largely determined by their
phosphorylation status [23] and nicotine-induced survival may
occur through multisite phosphorylation of BAD and phosphor-
ylation of BCL2 [24,25].
The observed increase in BCL2 could also be responsible for the
decrease in BAD transcription. Silencing of BCL2 leads to the
induction of p53-dependent apoptosis in colorectal cancer cells
[26]. Therefore, it is possible that cigarette smoking increases
BCL2 expression and that this indirectly leads to a decrease in BAD
expression through suppression of p53. Whatever the mechanism
it is clear that in multiple cell types smoking influences cell
turnover. One of the effects of smoking on the FT may be the
alteration of the rations of cell death and cell proliferation.
We assessed the effect of the dysregulation of BAD and BCL2
expression by smoking on cell death and cell proliferation in the
FT. Overall we did not find clearly significant results. However the
trend for cell death, as assessed by cleaved caspase 3 immunola-
belling as well as CASP9 and CASP3 expression was towards
smoking being associated with a reduction. The opposite trend was
observed when proliferation was assessed by Ki-67 immunolabel-
ling and CCDN1 expression. It is possible that the techniques we
used are not sensitive enough to pick up clear effects of BAD and
BCL2 dysregulation. However, taken together there does seem to
be a trend towards altered epithelial cell turnover in the FT as a
result of smoking. This is supported by our observation about the
structural changes in the epithelium of smokers, an effect
highlighted by BAD immunostaining. Although smokers showed
more epithelial blebbing than non-smokers, the significance of this
is not clear. Blebbing was not apparent in ciliated epithelial cells,
which may indicate that smokers have a reduction in cilia and/or
ciliated cells. Indeed the up-regulated cell survival gene BCL2
appeared to be exclusively expressed in the non-ciliated cells of the
epithelium and could be accounted for by a relative decrease in
ciliated cell numbers. However, a recent retrospective cohort study
of the effects of cigarette smoke on epithelial ciliation and
ciliogenesis in human FT did not reveal any significant changes
in ciliated cell numbers or transcription factors involved in
ciliogenesis [27].
Alternatively, changes in the relative levels on BAD and BCL2
may promote an environment suited to embryo attachment in the
FT. During intrauterine implantation, the endometrial epithelial
and stroma cells avert apoptosis and proliferate, undergoing a
process called decidualization, forming an environment that
promotes embryo attachment and invasion [28]. A recent study
has suggested that the preimplantation uterus relies on the
signaling Notch family of transmembrane receptors (specifically
Notch1) to inhibit apoptosis and regulate cell cycle progression
[28]. It is therefore possible that reduced BAD and increased BCL2
expression in the Fallopian tube, as a result of cigarette smoking,
predisposes the tubal microenvironment to implantation through
dysregulation of apoptosis and cell proliferation, factors important
for embryo receptivity.
We have demonstrated molecular structural effects of smoking
on the FT that may affect its function. Notwithstanding the
mechanism of these changes, our observations suggest that
cigarette smoking appears to promote a pro-survival and anti-
apoptotic microenvironment in the Fallopian tube. This coupled
with the previously reported effects on prokineticin reception [9]
could explain the association between smoking and ectopic
pregnancy. We have suggested a possible mechanism by which
smoking both alters tubal motility and promotes a tubal
environment that is favorable to ectopic implantation.
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